Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma.

Current Drug Targets
Lei ChengWei-Min Mao

Abstract

Malignant pleural mesothelioma (MPM) is a remarkably aggressive thoracic malignancy with a limited survival of only 5-12 months. However, MPM still remains unresponsive to conventional standards of treatment, including pleurectomy and decortication, extrapleural pneumonectomy for resectable disease with or without chemotherapy, and/or radiation therapy. The mechanism of carcinogenesis has not been fully elucidated, although approximately 80% of cases can still be linked to asbestos exposure. The tumor immune microenvironment (TME) has been proven to play an important role in MPM pathogenesis and treatment outcomes. Several molecular pathways have been implicated in the MPM tumor microenvironment, such as angiogenesis, apoptosis, cell cycle regulation, and stromal processes. Immunotherapy has already shown promising results in other thoracic solid tumors, such as non-small-cell lung cancer (NSCLC). However, immunotherapy has shown less convincing results in MPM than in melanoma and NSCLC. A multicenter, randomized trial (DETERMINE) proved that immune checkpoint inhibition using tremelimumab, an anti-cytotoxic T lymphocyteassociated protein 4 (CTLA-4) antibody, failed to improve median overall survival. Therefore, it is important...Continue Reading

References

May 18, 2001·Nature·L A Liotta, E C Kohn
Apr 2, 2005·Nature Reviews. Immunology·Jacques Banchereau, A Karolina Palucka
Mar 17, 2006·The European Respiratory Journal·J P J J HegmansB N Lambrecht
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·M EgebladZ Werb
Apr 1, 2008·The Journal of Thoracic and Cardiovascular Surgery·Masaki AnrakuMarc de Perrot
Dec 15, 2010·American Journal of Respiratory Cell and Molecular Biology·Megumi MaedaTakemi Otsuki
Mar 18, 2011·Journal of Cellular Physiology·Michele CarboneHaining Yang
Sep 14, 2011·Cancer Immunology, Immunotherapy : CII·Adam J BogradPrasad S Adusumilli
Nov 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michele Carbone, Haining Yang
Dec 27, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Thierry JahanHedy Lee Kindler
Mar 14, 2012·Future Oncology·Federica Grosso, Giorgio Vittorio Scagliotti
Oct 17, 2012·Cancer Immunology, Immunotherapy : CII·Melanie J McCoyRichard A Lake
Feb 12, 2013·The American Journal of Pathology·Brooke T MossmanRaffit Hassan
Mar 2, 2013·American Journal of Respiratory Cell and Molecular Biology·Naoko Kumagai-TakeiTakemi Otsuki
Jul 11, 2014·Current Opinion in Pharmacology·Joost P J J Hegmans, Joachim G J V Aerts
Apr 7, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robin CornelissenJoachim G J V Aerts
May 15, 2015·Nature·Stefani SprangerThomas F Gajewski
May 17, 2015·Cancer Treatment Reviews·V PanouO D Røe
Aug 21, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisAndrew G Nicholson
Jun 28, 2016·Molecular Therapy Oncolytics·Xiuyan Wang, Isabelle Rivière
Jul 16, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anne-Laure ChénéChristophe Blanquart
Feb 22, 2017·Frontiers in Immunology·Louise A ElliottElizabeth J Ryan
Jul 26, 2017·Nature Reviews. Cancer·Timothy A YapDean A Fennell
Nov 7, 2017·Asia-Pacific Journal of Clinical Oncology·Bella Hai NguyenSayed Ali
Jan 30, 2018·Cellular & Molecular Immunology·Lijie ZhaiDerek A Wainwright
Mar 8, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PaselloF Calabrese
Apr 6, 2018·JCI Insight·Hyun-Sung LeeBryan M Burt
Aug 25, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yannis MetaxasThomas John
Apr 25, 2019·International Journal of Cancer. Journal International Du Cancer·Rosa SottileEnnio Carbone
Feb 24, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giuseppe BronteLucio Crinò

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis